Susquehanna International Group
SIOX

Susquehanna International Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Susquehanna International Group’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-95,387
Closed -$41.5K – 14022
2022
Q4 		$41.5K Buy
+95,387
New +$31K ﹤0.01% 11485
2022
Q3 		– Sell
-57,187
Closed -$20K – 14556
2022
Q2 		$20K Sell
57,187
-4,546
-7% -$1.88K ﹤0.01% 12371
2022
Q1 		$41K Sell
61,733
-48,092
-44% -$40.8K ﹤0.01% 12398
2021
Q4 		$142K Buy
109,825
+82,264
+298% +$146K ﹤0.01% 11859
2021
Q3 		$60K Buy
27,561
+12,937
+88% +$28.1K ﹤0.01% 12288
2021
Q2 		$40K Sell
14,624
-97,917
-87% -$243K ﹤0.01% 12346
2021
Q1 		$294K Sell
112,541
-84,515
-43% -$239K ﹤0.01% 10648
2020
Q4 		$548K Buy
197,056
+11,301
+6% +$32.9K ﹤0.01% 8084
2020
Q3 		$858K Buy
185,755
+165,833
+832% +$547K ﹤0.01% 6492
2020
Q2 		$56K Buy
19,922
+2,987
+18% +$9.58K ﹤0.01% 9719
2020
Q1 		$41K Sell
16,935
-35,854
-68% -$129K ﹤0.01% 9753
2019
Q4 		$270K Sell
52,789
-25,562
-33% -$142K ﹤0.01% 8221
2019
Q3 		$506K Buy
+78,351
New +$540K ﹤0.01% 7289
2019
Q2 		– Sell
-19,604
Closed -$149K – 11036
2019
Q1 		$209K Buy
19,604
+4,738
+32% +$47.2K ﹤0.01% 7821
2018
Q4 		$118K Sell
14,866
-11,274
-43% -$163K ﹤0.01% 8135
2018
Q3 		$506K Sell
26,140
-5,882
-18% -$107K ﹤0.01% 6504
2018
Q2 		$579K Sell
32,022
-3,235
-9% -$47.7K ﹤0.01% 6497
2018
Q1 		$375K Buy
+35,257
New +$566K ﹤0.01% 7220
2017
Q2 		– Sell
-9,011
Closed -$1.58M – 10025
2017
Q1 		$1.08M Sell
9,011
-2,075
-19% -$217K ﹤0.01% 4978
2016
Q4 		$1.1M Buy
+11,086
New +$1.17M ﹤0.01% 5311
2015
Q4 		– Sell
-4,305
Closed -$560K – 10143
2015
Q3 		$445K Buy
+4,305
New +$505K ﹤0.01% 7342

Other funds holding SIOX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Susquehanna International Group's SIOX Position: Q1 2023 in Review

Susquehanna International Group sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 95,387 shares — an estimated $41.5K sold.

Susquehanna International Group first reported a position in SIOX in Q3 2015 and held it in 21 quarters. The position peaked at $1.1M in Q4 2016. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Susquehanna International Group reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 95,387 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $41.5K.
  • Susquehanna International Group first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 21 quarters.
  • Susquehanna International Group's Sio Gene Therapies Inc. Common Stock position peaked at $1.1M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.